Australia's Own Independent Prescription Drug Reference
AMH, Australia’s national prescription drug reference, is a joint project of the Pharmaceutical Society of Australia (PSA), the Royal Australian College of General Practitioners (RACGP) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).
AMH is the indispensable drug reference for Australian healthcare professionals, with a reputation for independence and accuracy second to none. AMH is continuously updated by an expert editorial team of pharmacists and medical practitioners. AMH has a distinguished Editorial Advisory Board and reviewers drawn from
                many of Australia’s leading educational and medical institutions.
AMH contains no drug company advertising. In fact, in line with our strict policy of total independence, AMH does not accept any commercial advertising or sponsorship, or direct editorial input, from any outside sources. AMH staff critically review information and evidence from a wide range of resources. For example, AMH first raised questions over cardiovascular safety with selective NSAIDS (COX-2 inhibitors) in our January 2002 edition - over two years before the Rofecoxib (Vioxx) ban and subsequent ongoing debate.
In addition to the 932-page Book version, AMH is also available in these electronic versions:
CD-ROM               PDA(Pocket PC) Online
The essential reference tool for medical practitioners, pharmacists, nurses, students, hospitals, aged care facilities, etc.